| Full Name | Ming-hui Fan |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Critical Care Medicine |
| Location | 55 Fruit St, Boston, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063561694 | NPI | - | NPPES |
| Entity Name | Washington Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316917669 PECOS PAC ID: 6103719562 Enrollment ID: O20040209000011 |
News Archive
Microfluidic Systems, a privately-held company, announced today it has been awarded a series of new patents covering both the components and integrated systems that perform fully automated sample collection through identification of air-borne pathogens such as bacteria, viruses, and toxins. Patent number 7,705,739 entitled "Integrated Airborne Substance Collection and Detection System" covers a combined instrument in which a detect-to-warn component is integrated with a detect-to-treat system.
A clinical trial has begun to examine the safety and use of two HIV prevention tools-oral pre-exposure prophylaxis and a vaginal ring-in adolescent girls and young women in southern Africa.
Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, is pleased to announce that it has treated the final patient of its Phase I clinical trial which evaluates the safety and preliminary efficacy of TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for hepatocellular carcinoma, the most common type of liver cancer.
The Michigan Chamber of Commerce will be launching a statewide private health insurance marketplace – Michigan's Insurance Marketplace at www.MiChamberMarketplace.org – on September 1, 2014.
› Verified 9 days ago
| Entity Name | Upmc Community Medicine Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558976092 PECOS PAC ID: 2062318975 Enrollment ID: O20040217000388 |
News Archive
Microfluidic Systems, a privately-held company, announced today it has been awarded a series of new patents covering both the components and integrated systems that perform fully automated sample collection through identification of air-borne pathogens such as bacteria, viruses, and toxins. Patent number 7,705,739 entitled "Integrated Airborne Substance Collection and Detection System" covers a combined instrument in which a detect-to-warn component is integrated with a detect-to-treat system.
A clinical trial has begun to examine the safety and use of two HIV prevention tools-oral pre-exposure prophylaxis and a vaginal ring-in adolescent girls and young women in southern Africa.
Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, is pleased to announce that it has treated the final patient of its Phase I clinical trial which evaluates the safety and preliminary efficacy of TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for hepatocellular carcinoma, the most common type of liver cancer.
The Michigan Chamber of Commerce will be launching a statewide private health insurance marketplace – Michigan's Insurance Marketplace at www.MiChamberMarketplace.org – on September 1, 2014.
› Verified 9 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
Microfluidic Systems, a privately-held company, announced today it has been awarded a series of new patents covering both the components and integrated systems that perform fully automated sample collection through identification of air-borne pathogens such as bacteria, viruses, and toxins. Patent number 7,705,739 entitled "Integrated Airborne Substance Collection and Detection System" covers a combined instrument in which a detect-to-warn component is integrated with a detect-to-treat system.
A clinical trial has begun to examine the safety and use of two HIV prevention tools-oral pre-exposure prophylaxis and a vaginal ring-in adolescent girls and young women in southern Africa.
Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, is pleased to announce that it has treated the final patient of its Phase I clinical trial which evaluates the safety and preliminary efficacy of TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for hepatocellular carcinoma, the most common type of liver cancer.
The Michigan Chamber of Commerce will be launching a statewide private health insurance marketplace – Michigan's Insurance Marketplace at www.MiChamberMarketplace.org – on September 1, 2014.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ming-hui Fan, MD 3400 Spruce St, 1 Maloney Building, Philadelphia, PA 19104-4206 Ph: (215) 614-0072 | Ming-hui Fan, MD 55 Fruit St, Boston, MA 02114-2696 Ph: (617) 643-7972 |
News Archive
Microfluidic Systems, a privately-held company, announced today it has been awarded a series of new patents covering both the components and integrated systems that perform fully automated sample collection through identification of air-borne pathogens such as bacteria, viruses, and toxins. Patent number 7,705,739 entitled "Integrated Airborne Substance Collection and Detection System" covers a combined instrument in which a detect-to-warn component is integrated with a detect-to-treat system.
A clinical trial has begun to examine the safety and use of two HIV prevention tools-oral pre-exposure prophylaxis and a vaginal ring-in adolescent girls and young women in southern Africa.
Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, is pleased to announce that it has treated the final patient of its Phase I clinical trial which evaluates the safety and preliminary efficacy of TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for hepatocellular carcinoma, the most common type of liver cancer.
The Michigan Chamber of Commerce will be launching a statewide private health insurance marketplace – Michigan's Insurance Marketplace at www.MiChamberMarketplace.org – on September 1, 2014.
› Verified 9 days ago
Kaitlyn My-tu Lam, MBBS Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-724-7738 | |
Kui Toh Gerard Leong, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit Street, Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-8862 | |
Ruma Rajbhandari, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-525-6841 | |
Alaka Ray, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2066 | |
Meghan E Sise, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2862 | |
Aaron Dickstein, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Box 233, Boston, MA 02111 Phone: 617-636-5883 Fax: 617-636-9292 | |
Dr. Felicia Elizabeth Patch, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 Massachusetts Ave, Crosstown 2, Boston, MA 02118 Phone: 617-414-4376 Fax: 617-414-4676 |